161 related articles for article (PubMed ID: 32051890)
1. Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone.
Miller S; Li P; Schipper M; Junck L; Piert M; Lawrence TS; Tsien C; Cao Y; Kim MM
Adv Radiat Oncol; 2020; 5(1):53-61. PubMed ID: 32051890
[TBL] [Abstract][Full Text] [Related]
2. Hotspot on 18F-FET PET/CT to Predict Aggressive Tumor Areas for Radiotherapy Dose Escalation Guiding in High-Grade Glioma.
Allard B; Dissaux B; Bourhis D; Dissaux G; Schick U; Salaün PY; Abgral R; Querellou S
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612093
[TBL] [Abstract][Full Text] [Related]
3. PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival.
Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Chang YH; Cheng MF; Shih TT
J Magn Reson Imaging; 2021 Jan; 53(1):305-318. PubMed ID: 32798280
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of volume-based FDG PET/CT parameters in patients with locally advanced pancreatic cancer treated with chemoradiation therapy.
Choi HJ; Lee JW; Kang B; Song SY; Lee JD; Lee JH
Yonsei Med J; 2014 Nov; 55(6):1498-506. PubMed ID: 25323885
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
6. The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan.
Romesser PB; Lim R; Spratt DE; Setton J; Riaz N; Lok B; Rao S; Sherman EJ; Schöder H; Lee NY
Oral Oncol; 2014 Sep; 50(9):802-8. PubMed ID: 25043882
[TBL] [Abstract][Full Text] [Related]
7. Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer.
Lee P; Bazan JG; Lavori PW; Weerasuriya DK; Quon A; Le QT; Wakelee HA; Graves EE; Loo BW
Clin Lung Cancer; 2012 Jan; 13(1):52-58. PubMed ID: 21703935
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.
Yoo MY; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kim EE; Kang KW
Nucl Med Mol Imaging; 2015 Dec; 49(4):291-7. PubMed ID: 26550048
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of post-treatment metabolic tumor volume from
Jung TY; Min JJ; Bom HS; Jung S; Kim IY; Lim SH; Kim DY; Kwon SY
Neurosurg Rev; 2017 Apr; 40(2):223-229. PubMed ID: 27282449
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer.
Kim J; Lim ST; Na CJ; Han YH; Kim CY; Jeong HJ; Sohn MH
Nucl Med Mol Imaging; 2014 Mar; 48(1):33-40. PubMed ID: 24900136
[TBL] [Abstract][Full Text] [Related]
11. C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.
Wang Y; Rapalino O; Heidari P; Loeffler J; Shih HA; Oh K; Mahmood U
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1024-1028. PubMed ID: 29913253
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy.
Shrestha S; Higuchi T; Shirai K; Tokue A; Shrestha S; Saitoh JI; Hirasawa H; Ohno T; Nakano T; Tsushima Y
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1220-1227. PubMed ID: 31758225
[TBL] [Abstract][Full Text] [Related]
14. Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal.
Bazan JG; Koong AC; Kapp DS; Quon A; Graves EE; Loo BW; Chang DT
J Nucl Med; 2013 Jan; 54(1):27-32. PubMed ID: 23236018
[TBL] [Abstract][Full Text] [Related]
15. Hypercellularity Components of Glioblastoma Identified by High b-Value Diffusion-Weighted Imaging.
Pramanik PP; Parmar HA; Mammoser AG; Junck LR; Kim MM; Tsien CI; Lawrence TS; Cao Y
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):811-9. PubMed ID: 26104935
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
17.
Vallius T; Hynninen J; Kemppainen J; Alves V; Auranen K; Matomäki J; Oksa S; Virtanen J; Grénman S; Auranen A; Seppänen M
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1224-1232. PubMed ID: 29476227
[TBL] [Abstract][Full Text] [Related]
18. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.
Murphy JD; La TH; Chu K; Quon A; Fischbein NJ; Maxim PG; Graves EE; Loo BW; Le QT
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):514-21. PubMed ID: 20646870
[TBL] [Abstract][Full Text] [Related]
19. Use of
Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
[No Abstract] [Full Text] [Related]
20. Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
Duimering A; Riauka T; Nijjar Y; Ghosh S; MacEwan R; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Nijjar T; Fairchild A; Mulder K; Doll C; Wong C; Joseph K
Radiother Oncol; 2019 Jul; 136():21-28. PubMed ID: 31015125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]